{"Title": "Analysis of the polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer", "Year": 2015, "Source": "Clin. Epigenetics", "Volume": "7", "Issue": 1, "Art.No": null, "PageStart": null, "PageEnd": null, "CitedBy": 46, "DOI": "10.1186/s13148-015-0141-x", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84943338445&origin=inward", "Abstract": "\u00a9 2015 Mart\u00ednez-Fern\u00e1ndez et al.Background: Long non-coding RNAs (lncRNAs) have been claimed as key molecular players in gene expression regulation, being involved in diverse epigenetic processes. They are aberrantly expressed in various tumors, but their exact role in bladder cancer is still obscure. We have recently found a major role of the Polycomb repression complex in recurrence of non-muscle-invasive bladder cancer. Here, we report the xpression of Polycomb-related lncRNAs:antisense noncoding RNA in the INK4 locus (ANRIL) and HOX antisense intergenic RNA (HOTAIR) in these tumors. Findings: We studied a dataset of non-invasive bladder cancer samples by quantitative reverse transcription PCR (RT-qPCR) and analyzed also invasive bladder cancer samples using TCGA data. Our results showed that, while ANRIL seemed not to have a determining role, an increased HOTAIR expression appeared in recurrent and high-graded tumors associated with poor prognosis. In addition, through genome-wide transcriptome analyses, we observed that HOTAIR-EZH2-complex-regulated genes can efficiently discriminate between non-tumoral, recurrent, and non-recurrent bladder cancer samples. We also observed a significant correlation between EZH2 and HOTAIR expression levels. Using overexpression, knockdown, and pharmacological approaches in bladder cancer cell lines, we also observed that EZH2 regulates HOTAIR expression. Conclusions: Our findings indicate that HOTAIR expression has prognostic value for bladder cancer progression, recurrence, and survival and suggest that HOTAIR plays active roles in modulating the cancer epigenome, becoming an interesting candidate as a target for cancer diagnosis and therapy. The observed HOTAIR regulation by EZH2 and the possibility of modulating EZH2 activity with specific inhibitors open new possible paths to be explored in bladder cancer therapy.", "AuthorKeywords": ["ANRIL", "Bladder cancer", "Epigenetics", "HOTAIR", "LncRNA", "Recurrence"], "IndexKeywords": null, "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-84943338445", "SubjectAreas": [["Molecular Biology", "BIOC", "1312"], ["Genetics", "BIOC", "1311"], ["Developmental Biology", "BIOC", "1309"], ["Genetics (clinical)", "MEDI", "2716"]], "AuthorData": {"8535731400": {"Name": "Mart\u00ednez-Fern\u00e1ndez M.", "AuthorID": "8535731400", "AffiliationID": "60004024, 60009196", "AffiliationName": "Biomedical Research Institute I+12, University Hospital \u201c12 de Octubre\u201d"}, "57206503433": {"Name": "Due\u00f1as M.", "AuthorID": "57206503433", "AffiliationID": "60004024, 60009196", "AffiliationName": "Biomedical Research Institute I+12, University Hospital \u201c12 de Octubre\u201d"}, "6603538785": {"Name": "Segovia C.", "AuthorID": "6603538785", "AffiliationID": "60004024, 60009196", "AffiliationName": "Biomedical Research Institute I+12, University Hospital \u201c12 de Octubre\u201d"}, "56890583500": {"Name": "Rubio C.", "AuthorID": "56890583500", "AffiliationID": "60004024, 60009196", "AffiliationName": "Biomedical Research Institute I+12, University Hospital \u201c12 de Octubre\u201d"}, "57193237172": {"Name": "Fernandez M.", "AuthorID": "57193237172", "AffiliationID": "60004024, 60009196", "AffiliationName": "Biomedical Research Institute I+12, University Hospital \u201c12 de Octubre\u201d"}, "56891736700": {"Name": "L\u00f3pez-Calder\u00f3n F.", "AuthorID": "56891736700", "AffiliationID": "60004024, 60009196", "AffiliationName": "Biomedical Research Institute I+12, University Hospital \u201c12 de Octubre\u201d"}, "6701734556": {"Name": "Paramio J.", "AuthorID": "6701734556", "AffiliationID": "60004024, 60009196", "AffiliationName": "Biomedical Research Institute I+12, University Hospital \u201c12 de Octubre\u201d"}, "15748766900": {"Name": "Villacampa F.", "AuthorID": "15748766900", "AffiliationID": "60004024, 60009196", "AffiliationName": "Biomedical Research Institute I+12, University Hospital \u201c12 de Octubre\u201d"}, "55920733400": {"Name": "Duarte J.", "AuthorID": "55920733400", "AffiliationID": "60004024, 60009196", "AffiliationName": "Biomedical Research Institute I+12, University Hospital \u201c12 de Octubre\u201d"}, "57052737100": {"Name": "G\u00f3mez-Rodriguez M.", "AuthorID": "57052737100", "AffiliationID": "60004024, 60009196", "AffiliationName": "Biomedical Research Institute I+12, University Hospital \u201c12 de Octubre\u201d"}, "55901642500": {"Name": "Castellano D.", "AuthorID": "55901642500", "AffiliationID": "60004024, 60009196", "AffiliationName": "Biomedical Research Institute I+12, University Hospital \u201c12 de Octubre\u201d"}, "7005762332": {"Name": "Rodriguez-Peralto J.", "AuthorID": "7005762332", "AffiliationID": "60004024, 60027282", "AffiliationName": "Servicio de Anatom\u00eda Patol\u00f3gica, Hospital Universitario 12 de Octubre, Instituto de Investigaci\u00f3n 12 de Octubre i+12, UCM"}, "7004087843": {"Name": "De La Rosa F.", "AuthorID": "7004087843", "AffiliationID": "60004024, 60009196", "AffiliationName": "Biomedical Research Institute I+12, University Hospital \u201c12 de Octubre\u201d"}, "6506954566": {"Name": "Feber A.", "AuthorID": "6506954566", "AffiliationID": "60109234, 60022148", "AffiliationName": "Medical Genomics, UCL Cancer Institute, University College London"}, "57193033325": {"Name": "Beck S.", "AuthorID": "57193033325", "AffiliationID": "60109234, 60022148", "AffiliationName": "Medical Genomics, UCL Cancer Institute, University College London"}}}